(Q37328301)

English

Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma

scientific article published on 28 July 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1 reference

based on heuristic

inferred from title

author name string

Erik E Johnson

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Brett H Yamane

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Ilia N Buhtoiarov

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Hillary D Lum

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Alexander L Rakhmilevich

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

David M Mahvi

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Stephen D Gillies

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Paul M Sondel

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

28 July 2009

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

4875-4884

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Intratumoral immunocytokine treatment results in enhanced antitumor effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

RFA for liver tumors: does it really work?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Radiofrequency ablation in patients with primary and secondary hepatic malignancies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

In-situ ablation of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Liver ablation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Frequent EpCam protein expression in human carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

What does it take to make a natural killer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Thermal ablation therapy for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Antibody-directed, effector cell-mediated tumor destruction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Tumor ablation with radio-frequency energy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

6 September 2017

In situ tumor ablation creates an antigen source for the generation of antitumor immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

14 September 2017

Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

14 September 2017

Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

28 September 2017

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

28 September 2017

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

26 June 2018

Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

26 June 2018

Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

26 June 2018

Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

2 September 2018

Safety, pharmacokinetics, and biological pharmacodynamics of the immunocytokine EMD 273066 (huKS-IL2): results of a phase I trial in patients with prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

2 September 2018

NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

2 September 2018

Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

2 September 2018

Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

2 September 2018

Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

2 September 2018

Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

2 September 2018

Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

2 September 2018

Rates and Patterns of Recurrence for Percutaneous Radiofrequency Ablation and Open Wedge Resection for Solitary Colorectal Liver Metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

3 December 2018

Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735865

3 December 2018

Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiofrequency Ablation of Malignant Liver Tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiofrequency Ablation of 100 Hepatic Metastases with a Mean Follow-Up of More Than 1 Year

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ga733/EpCAM as a target for passive and active specific immunotherapy in patients with colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19638464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-09-0110

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37328301&oldid=2099150237"